| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $910K | +3.4% |
| SG&A Expense | $2.1M | +27.1% |
| Pre-tax Income | -$3.3M | -17.1% |
| Net Income | -$3.3M | -17.1% |
| EPS (Basic) | -$0.16 | -14.3% |
| EPS (Diluted) | -$0.16 | -14.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Current Assets | $6.0M | +97.7% |
| Total Assets | $6.5M | +46.0% |
| Current Liabilities | $2.9M | +5.7% |
| Total Liabilities | $3.0M | +8.5% |
| Stockholders' Equity | $3.5M | +109.1% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | -173.9% |
| Capital Expenditures | $32K | -57.3% |
| Investing Cash Flow | -$32K | +57.3% |
| Financing Cash Flow | $5.9M | +217.9% |
| Free Cash Flow | -$5.9M | -166.2% |